Search Results - "Herrero, C. Camps"

Breakthrough cancer pain: review and calls to action to improve its management by Camps Herrero, C., Batista, N., Díaz Fernández, N., Escobar Álvarez, Y., Gonzalo Gómez, A., Isla Casado, D., Salud, A., Terrasa Pons, J., Guillem Porta, V.

“…In this paper, we review the current state of breakthrough cancer pain (BTcP) management. BTcP is a heterogeneous condition and a global problem for cancer…”
Get full text

Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis by Gil-Raga, M., Jantus-Lewintre, E., Gallach, S., Giner-Bosch, V., Frangi-Caregnato, A., Safont-Aguilera, M. J., Garde-Noguera, J., Zorraquino-Pina, E., García-Martínez, M., Camps-Herrero, C.

“…Purpose After surgical resection, an ample prognosis variability among stages is observed. Multiple prognostic factors are individually studied and some CRC…”
Get full text

Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP) by Camps Herrero, C., Reina Zoilo, J. J., Monge Martín, D., Caballero Martínez, F., Guillem Porta, V., Aranda Aguilar, E., Carrato Mena, A., Díaz-Rubio García, E., García-Foncillas López, J., Feijóo Saus, M., López López, R.

“…Aims To prove if there is clinical inertia in the identification and treatment of episodes of breakthrough cancer pain (BTcP), comparing actual results from…”
Get full text

Oncologist’s knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study by López López, R., Camps Herrero, C., Khosravi-Shahi, P., Guillem Porta, V., Carrato Mena, A., Garcia-Foncillas, J., Cruz Hernández, J. J., Gascón Vilaplana, P., Antón Torres, A., Diaz-Rubio, E., Feyjoo Saus, M., Aranda Aguilar, E.

“…Purpose Breakthrough cancer pain (BTcP) has been shown to be a prevalent and poor prognostic factor for oncologic patients, which remain under diagnosed and…”
Get full text

High pKDR immunohistochemical expression is an unfavourable prognostic biomarker in patients with advanced colorectal cancer treated with chemotherapy plus bevacizumab by Garde-Noguera, J., Gil-Raga, M., Evgenyeva, E., García, J. A., Llombart-Cussac, A., Camps-Herrero, C.

“…Purpose To analyse the prognostic role of the immunohistochemical expression of pKDR in patients with advanced colorectal cancer treated with oxaliplatin and…”
Get full text

Management of malignant insulinoma by Ferrer-García, J. C., Iranzo González-Cruz, V., Navas-DeSolís, S., Civera-Andrés, M., Morillas-Ariño, C., Merchante-Alfaro, Á., Caballero-Díaz, C., Sánchez-Juan, C., Camps Herrero, C.

“…Aim Malignant insulinoma is an infrequent functional endocrine tumor of the pancreas. Adequate therapy is a demanding challenge for oncologists and…”
Get full text

Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists by Camps-Herrero, C., Paz-Ares, L., Codes, M., López-López, R., Antón-Torres, A., Gascón-Vilaplana, P., Guillem-Porta, V., Carrato, A., Cruz-Hernández, J. J., Caballero-Díaz, C., Blasco-Cordellat, A., Moreno-Nogueira, J. A., Díaz-Rubio, E.

“…Purpose The economic situation showed that the resources devoted to health spending are limited, making rationalisation of their consumption necessary. The…”
Get full text

2250P Exploring tumor microenvironment in lung cancer through patient-derived 3D models by Juciute, N., Boada-Acosta, L.A., Torres-Martínez, S., Escorihuela, E., Maravilla, E. Munera, Mosqueda-Frometa, M., Castellote-Borrell, M., Rodriguez, A., Miranda, N., Roz, L., Navarro-Cerveró, L., Blanco, B., Guasch, J., Guijarro, R., Pastor-Martinez, E., Fariñas, S. Calabuig, Herrero, C. Camps, Lewintre, E. Jantus

Get full text

Farmacoeconomía y los costes de los medicamentos contra el cáncer by Camps Herrero, C., Caballero Díaz, C., Blasco Cordellat, A.

“…El cáncer es una enfermedad de elevada incidencia, lo que condiciona que los sistemas de salud se vean obligados a destinarle un importante volumen de…”
Get full text

1819PClinical practice evaluation of opioids induced constipation management in cancer patients: The EIO-Praxis project by Aranda Aguilar, E, Garcia Foncillas, J, Antón, A, Camps Herrero, C J, Carrato Mena, A, Constenla Figueiras, M, Cruz Hernandez, J J, Diaz Rubio, E, Gascon, P N, Guillem Porta, V, López, R, Feyjóo, M, Puente, J

“…Abstract Background In 2017, the ECO Foundation (Excellence and Quality in Oncology) completed the EIO-50 project to learn about the diagnostic and treatment…”
Get full text

1924PExosomes in NSCLC as a source of biomarkers by Duréndez, E, Calabuig-Fariñas, S, Suarez, C, Mosqueda, M, Moreno-Manuel, A, Torres Martinez, S, Herreros Pomares, A, Gallach, S, Escorihuela, E, de la Cueva, E, Martinez-Romero, A, Serna, E, Paramio, J M, Jantus-Lewintre, E, Camps Herrero, C J

“…Abstract Background Exosomes are small membranous vesicles (around 40-130 nm), that have been detected in different biological samples, that play a key role in…”
Get full text

Tumor microenvironment in high serous ovary cancer: Characterization of the infiltration pattern and analysis of its prognostic value by Herrera Cañizares, F., Chipirliu, A., Caballero, C., Herreros Pomares, A., Calabuig Fariñas, S., Valdivieso, L., Mosqueda, M., Marí Alexandre, J., Jantus Lewintre, E., Gilabert, J., Camps Herrero, C.

Get full text

Stemness characterization of tumorspheres from non-small cell lung cancer: Differential expression in CSC-related markers and signaling pathways by Herreros Pomares, A., Calabuig Fariñas, S., Escorihuela, E., Amado, H., Guijarro, R., Gallach Garcia, S., Navarro, A., Jantus-Lewintre, E., Camps Herrero, C.

Get full text

Characterization of cancer stem cell and immune microenvironment interactions in non-small cell lung cancer (NSCLC) by Torres, S., Sirera, R., Aguilar, C., Calabuig Fariñas, S., Mosqueda, M., Herreros-Pomares, A., Escorihuela, E., García del Olmo, E., Jantus-Lewintre, E., Camps Herrero, C.

Get full text

1845PTobacco use in lung cancer (LC) patients (p) in Spain by Carcereny Costa, E, Guirado, M, Camps Herrero, C J, Bosch Barrera, J, García-Campelo, M-R, Ortega Granados, A L, Gonzalez-Larriba, J L, De Dios Alvare, N, Domine Gomez, M, Massuti Sureda, B, Sala, M A, Bernabé, R, Oramas Rodriguez, J M, del Barco Morillo, E, Padilla, A, Aguiar Bujanda, D, Cerezo Gonzalez, S, Lopez Castro, R, Rodriguez Abreu, D, Provencio, M

“…Abstract Background Tobacco use, mainly as cigarette smoking, is the leading cause of lung cancer. Eighty-five percent of LC occur in smokers. Understanding…”
Get full text

1846PBiomarker testing of lung cancer in Spain by Rodriguez Abreu, D, Guirado, M, Camps Herrero, C J, Bosch Barrera, J, Bernabé, R, Casal, J, García-Campelo, M-R, Gonzalez-Larriba, J L, Massuti Sureda, B, Ortega Granados, A L, Domine Gomez, M, Sala, M A, Padilla, A, Del Barco Morillo, E, Oramas Rodriguez, J M, Blanco Guerrero, R, Aguiar Bujanda, D, López Castro, R, Carcereny Costa, E, Provencio, M

“…Abstract Background Target therapy guide by biomarkers have become the standard of care for patients with lung cancer (LC). So, identify those molecular…”
Get full text

How do Spanish medical oncologists manage breakthrough pain? A national study by Aranda, E., Camps Herrero, C., Khosravi, P., Feyjoo, M., Anton Torres, A., Gascon, P., Garcia Foncillas, J., Diaz Rubio, E., Guillem Porta, V., Carrato, A., Constenla Figueiras, M., Cruz Hernandez, J.J., López, R.

Get full text

Clinical value of cfDNA and CTCs in EGFR mutations detected in advanced NSCLC by Calabuig Fariñas, S., Jantus-Lewintre, E., Fernández, A., Mayo de las Casas, C., Blasco, A., Aguilar, C., Jordana, N., Balada, A., Garzón Ibañez, M., Zhang, F., Dong, N., Molina, M.A., Rosell, R., Camps Herrero, C.

Get full text

Analysis of immunoregulatory biomarkers in early stages of non-small cell lung cancer by Moreno Manuel, A., Calabuig Fariñas, S., Herreros Pomares, A., Gallach Garcia, S., Aranda, F., Blasco, A., Carreras, E., Lozano, F., Cunquero Tomas, A., Martorell, M., Jantus-Lewintre, E., Camps Herrero, C.

Get full text

23P Prognostic value of tumor-infiltrating lymphocytes (TILs) and soluble immune checkpoints in early triple-negative breast cancer (TNBC) by Abad, M. Nunez, García, J.Á. García, Torres-Martínez, S., Lobo de Mena, M., Ben Hammou El Majdoubi, F., Mosqueda-Frometa, M., Herrero, C. Camps, Fariñas, S. Calabuig, Iranzo, V.

Get full text